ESAB
ESAB
$69.27
-4.86%
ESAB Corporation is a leading manufacturer of welding, cutting, and joining equipment and consumables, operating within the global metal fabrication industry. As one of the top three players in the welding space alongside Lincoln Electric and ITW's Miller brand, ESAB holds a strong competitive position with a diverse product portfolio and a global footprint. The current investor narrative centers on the company's post-spin-off transformation, with attention on its ability to drive organic growth, expand margins through operational excellence, and navigate cyclical end-market demand. Recent market dynamics, including a sharp decline in the stock price amid broader industrial weakness and geopolitical events, have raised questions about near-term earnings momentum and the sustainability of its growth trajectory.…
ESAB
ESAB
$69.27
Investment Opinion: Should I buy ESAB Today?
Based on the analysis, ESAB is rated a Buy. The stock is trading at a significant discount to its intrinsic value, with a forward PE of 11.7x versus the market average of around 20x. The analyst consensus is a strong buy, with an average target price of $131.18, implying 71.6% upside. The company's strong operating margin of 17.3% and solid balance sheet support the thesis that earnings will recover. The key catalysts are margin expansion and cost savings, which could drive EPS from $2.54 to $9.86 as estimated by analysts. The stock is undervalued relative to its history and peers, making it an attractive investment for value-oriented investors.
Sign up to view all
ESAB 12-Month Price Forecast
The AI assessment is bullish with medium confidence. The valuation is compelling, with a forward PE of 11.7x, and the analyst consensus is strongly bullish. However, the stock is in a downtrend, and the earnings recovery is not guaranteed. The key factor is whether the company can deliver on the expected EPS of $9.86. If it does, the stock could re-rate significantly. If not, the downside is limited but could persist. The stance would be upgraded to high confidence if the company reports strong Q1 2026 earnings and raises guidance. It would be downgraded to neutral if revenue growth decelerates further or if the stock breaks below the 52-week low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on ESAB's 12-month outlook, with a consensus price target around $131.18 and implied upside of +89.4% versus the current price.
Average Target
$131.18
0 analysts
Implied Upside
+89.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$100 - $154
Analyst target range
The target price range spans from a low of $100.00 to a high of $154.00, representing a wide spread of 54% from low to high. The high target of $154.00 implies a potential upside of 101.5% from the current price, suggesting that some analysts see significant recovery potential, possibly driven by a cyclical rebound in industrial demand and margin expansion. The low target of $100.00 still implies an upside of 30.8%, indicating that even the most bearish analyst sees value at current levels. The wide range reflects high uncertainty about the timing and magnitude of the recovery, but the overall consensus is strongly bullish, with no downgrades in recent months. This suggests that the market may be overly pessimistic, and the stock could be a contrarian opportunity if the company executes on its growth plans.
Bulls vs Bears: ESAB Investment Factors
ESAB presents a classic value-versus-momentum conflict. The bearish case is anchored by a severe price decline, decelerating revenue growth, and negative relative strength, indicating persistent selling pressure. However, the bullish case is compelling: the forward PE of 11.7x implies the market expects a massive earnings recovery, and analysts see 72% upside with a strong buy consensus. The single most important tension is whether the expected earnings normalization (EPS from $2.54 to $9.86) is realistic. If the company can execute on margin expansion and cost savings, the stock is deeply undervalued; if not, the stock may continue to drift lower. Currently, the bearish momentum is stronger, but the valuation and analyst sentiment tilt the balance toward a contrarian opportunity.
Bullish
- Analyst consensus strong buy with 72% upside: The average analyst target price is $131.18, implying a 71.6% upside from the current price of $76.43. With a recommendation mean of 1.27 (strong buy) and 11 analysts covering, the sell-side sees significant recovery potential, likely driven by expected earnings normalization.
- Forward PE of 11.7x suggests undervaluation: The forward PE is 11.71x versus a trailing PE of 30.03x, indicating the market expects a dramatic earnings recovery. Estimated EPS of $9.86 for the next year would represent a 288% increase from trailing EPS of $2.54, implying the market is pricing in a strong margin rebound.
- Strong operating margin of 17.3%: ESAB's operating margin is 17.3%, reflecting efficient cost management and pricing power. This is a key driver of the expected earnings recovery, as even modest revenue growth can translate into significant EPS growth given the operating leverage.
- Solid balance sheet with manageable leverage: The debt-to-equity ratio is 0.66, indicating a moderate leverage level. The current ratio of 1.90 shows strong liquidity, providing financial flexibility to weather cyclical downturns and invest in growth initiatives.
Bearish
- Stock near 52-week low with -34.6% 1-year decline: The stock is trading at $76.43, just 0.8% above the 52-week low of $75.83, and has fallen 34.6% over the past year. This persistent downtrend reflects significant selling pressure and a lack of buyer conviction, suggesting the market is pricing in continued weakness.
- Revenue growth decelerating to 7.5% YoY: Q4 2025 revenue grew 7.5% YoY, but this is a slowdown from earlier quarters (Q1: 7.5%, Q2: 7.5%, Q3: 7.5% - actually Q3 was 8.1% and Q4 was 7.5%). The sequential decline from Q3's $727.8M to Q4's $721.0M indicates softening demand, which could pressure future growth.
- Negative relative strength vs S&P 500: ESAB's 1-year relative strength is -53.1%, meaning it has underperformed the S&P 500 by 53 percentage points. This massive underperformance highlights the stock's vulnerability to sector rotation and investor preference for other industrials.
- High short interest of 7.88 days to cover: The short ratio of 7.88 indicates elevated short interest, reflecting bearish sentiment among investors. This could lead to continued downward pressure, although it also sets up a potential short squeeze if positive news emerges.
ESAB Technical Analysis
ESAB is in a pronounced downtrend, with the stock price at $76.43 as of August 28, 2026, reflecting a 1-year decline of -34.57%. The current price sits near the 52-week low of $75.83, representing just 0.8% above the low and only 55.6% of the 52-week high of $137.42. This positioning near the bottom of the range suggests persistent selling pressure and a lack of buyer conviction, with the stock trading at a significant discount to its prior highs. The 6-month price change of -39.42% underscores the severity of the decline, indicating a sustained bearish phase rather than a mere pullback.
Beta
1.13
1.13x market volatility
Max Drawdown
-48.6%
Largest decline past year
52-Week Range
$68-$137
Price range past year
Annual Return
-39.0%
Cumulative gain past year
| Period | ESAB Return | S&P 500 |
|---|---|---|
| 1m | -21.2% | -1.6% |
| 3m | -24.4% | +2.2% |
| 6m | -29.3% | +14.4% |
| 1y | -39.0% | +16.2% |
| ytd | -38.5% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ESAB Fundamental Analysis
ESAB's revenue trajectory shows modest growth, with the most recent quarter (Q4 2025) reporting revenue of $720.99 million, a 7.49% year-over-year increase. However, this growth is decelerating from earlier quarters: Q1 2025 revenue was $678.14 million, Q2 was $715.59 million, and Q3 was $727.85 million, indicating a sequential slowdown in Q4. The full-year 2025 revenue was approximately $2.84 billion, up from $2.74 billion in 2024, reflecting a growth rate of about 3.6%. Revenue segments show Equipment Products contributing $1.41 billion and Consumable Products $42.7 million, though the latter appears to be a partial segment figure. The deceleration suggests that end-market demand is softening, which could pressure future growth.
Quarterly Revenue
$720986000.0B
2025-12
Revenue YoY Growth
+7.5%
YoY Comparison
Gross Margin
30.5%
Latest Quarter
Free Cash Flow
$213280000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ESAB Overvalued?
Given that ESAB is profitable, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 30.03x, while the forward PE is 11.71x, indicating that the market expects a significant earnings increase in the next year. This wide gap implies that the market is pricing in a substantial recovery in earnings, likely driven by margin expansion or cost savings. The forward PE of 11.71x is notably lower than the trailing multiple, suggesting that the current earnings are depressed and the market anticipates a normalization. This is supported by the estimated EPS of $9.86 for the next year, which would represent a dramatic increase from the current trailing EPS of approximately $2.54.
PE
30.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 10x~45x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company's revenue growth is decelerating, with Q4 2025 growth of 7.5% YoY, down from earlier quarters, and full-year growth of only 3.6%. This suggests softening end-market demand, which could pressure margins. The net margin is 7.98%, and operating margin is 17.3%, but these could compress if volumes decline. The debt-to-equity ratio of 0.66 is manageable, but interest expenses of $17.9M in Q4 2025 consume a portion of operating income. Free cash flow TTM is $213.3M, providing some buffer, but the company's reliance on continued growth to justify its forward PE is a key risk. If earnings do not recover as expected, the stock could face further de-rating.
FAQ
The key risks are: 1) Financial risk: revenue growth is decelerating, and if it turns negative, margins could compress. The debt-to-equity ratio is 0.66, which is manageable, but interest expenses are a drag. 2) Market risk: the stock has a beta of 1.149, making it more volatile than the market. It has underperformed the S&P 500 by 53% over the past year, indicating sector rotation risk. 3) Competitive risk: competition from Lincoln Electric and ITW could limit pricing power. 4) Macro risk: a global recession would reduce demand for welding products. The most severe risk is a failure to achieve the expected earnings recovery, which could keep the stock depressed.
The 12-month forecast is bullish. The base case scenario, with a 50% probability, sees the stock trading between $100 and $120, with an average target of $131.18. The bull case, with a 30% probability, sees the stock reaching $120-$154, driven by a strong earnings recovery. The bear case, with a 20% probability, sees the stock staying near $75-$90 if the recovery fails. The most likely scenario is the base case, where the stock recovers to around $110, implying a 44% upside from the current price. The key assumption is that the company achieves its estimated EPS of $9.86.
ESAB is undervalued based on forward earnings. The forward PE is 11.7x, which is a discount to the market average of around 20x. The trailing PE is 30x, but this is distorted by depressed earnings. The market is pricing in a significant earnings recovery, with estimated EPS of $9.86 for the next year. If that recovery occurs, the stock is cheap. The PS ratio is 2.4x, which is reasonable for an industrial company. Compared to peers like Lincoln Electric, ESAB trades at a lower multiple, suggesting it is undervalued. The market is expecting a strong turnaround, and if it happens, the stock could re-rate higher.
ESAB is a good buy for investors with a contrarian, value-oriented approach. The stock is trading at $76.43, near its 52-week low, with a forward PE of 11.7x, which is significantly below the market average. Analysts have a strong buy consensus with an average target price of $131.18, implying 71.6% upside. The main risk is that the expected earnings recovery may not materialize, but the downside is limited given the stock is already near its low. For long-term investors who can tolerate volatility, the risk/reward is favorable. However, for short-term traders, the stock is in a downtrend, and there may be better entry points.
ESAB is more suitable for long-term investment. The stock is in a downtrend, and short-term trading is risky due to high volatility (beta 1.149) and negative momentum. However, for long-term investors, the stock offers a compelling value proposition with a forward PE of 11.7x and a strong competitive position. The company pays a small dividend (yield 0.32%), but the main return potential is from capital appreciation. A minimum holding period of 2-3 years is recommended to allow for the earnings recovery to play out. The stock is not suitable for income investors, but for growth and value investors with a long-term horizon, it could be a rewarding investment.